BioTime Inc (NYSE MKT LLC:BTX)

3.68
Delayed Data
As of Jul 02
 +0.11 / +3.08%
Today’s Change
2.33
Today|||52-Week Range
5.95
-1.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-16.5M-21.4M-43.9M-36.3M
 
 
 
 
 
Depreciation3.1M2.8M4.0M8.4M
 
 
 
 
 
Total Other Cash Flow-177.1K-1.6M10.9M-2.7M
 
 
 
 
 
Funds From Operations-13.6M-20.1M-32.3M-38.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-26.1K-468.0K-2.8M827.1K
 
 
 
 
 
Net Cash Flow - Operating Activities-13.6M-19.7M-29.5M-38.9M
 
 
 
 
 
 
InvestingDecrease In Investments0.00292.4K0.000.00
 
 
Capital Expenditures-960.3K-400.8K-2.3M-483.1K
 
 
 
 
 
Fixed Asset Disposal5.9K4.5K30.9K9.2K
 
 
 
 
 
Net Assets From Acquisitions -246.9K0.00-978.1K0.00
 
 
 
Other Investing - Uses-1.5K-764.00-441.2K-533.9K
 
 
 
 
 
Other Investing - Sources10.00--0.000.00
 
 
Net Cash Flow Investing-1.2M-104.7K-3.7M-1.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00470.9K
 
 
Long Term Debt Reduction0.000.000.00-26.2K
 
 
Net Proceeds Stock Sale3.9M1.9M34.3M63.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.9M1.9M34.3M63.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-178.8K8.9K56.1K230.2K
 
 
 
 
 
 
Net Change In Cash-10.9M-17.9M1.1M23.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account